echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Progress was made in the evaluation of silver ring snake toxin and clinical anti-silver ring snake serum

    Progress was made in the evaluation of silver ring snake toxin and clinical anti-silver ring snake serum

    • Last Update: 2021-03-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Snake injury is a tropical disease, due to economic reasons or lack of treatment drugs - anti-snake venom serum, resulting in snake injury patients have a higher disability rate and a certain mortality rate.
    The Biotoxin and Human Diseases Unit of the Kunming Institute of Zoology of the Chinese Academy of Sciences studied silver ring snakes and obtained high-purity a-bungarotoxin, b-bungarotoxin and g-bungarotoxin by traditional separation and purification methods.
    half of its lethal dose was measured by three different dosage methods, and it was determined that b-bungarotoxin was the most toxic and highly contained toxin, the most important component of silver ring snake bite death, and that individual anti-b-bungarotoxin antibodies were effective in mesolyticing silver ring snake toxin.
    , the researchers conducted antibody protection experiments on commercial anti-silver ring snake venom and nine species of poisonous snakes that were seriously harmful.
    the study found that commercial anti-silver ring snake venom blood removed can be mediumed silver ring snake toxin, cobra snake toxin also has a certain protective effect, but the cobra venom and the same species of silver ring snake snake venom basically no protective effect, this conclusion provides guidance and experimental basis for anti-silver ring snake serum treatment of snake injury.
    research results on Immunoreactivity and neutralization study of Chinese Bungarus multicinctus antivenin and lab-prepared anti-bungarotoxin antisera directs purified bungarotoxins and snake venoms were published in a cover article on PLoS Neglected Tropical Diseases.
    Wenhui, an associate researcher at Kunming Animal Institute in China, and Wu Xiaobing, a professor at the School of Life Sciences at Anhui Normal University, are co-authors of the paper.
    Lin Bo of Anhui Normal University and Zhang Jiarui, a graduate student at Guangzhou Medical University, are co-authors of the paper.
    research has been supported by Yunnan Province's key areas and key research and development programs.
    () 
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.